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Introduction 
The INTERMED Self-Assessment questionnaire (IM-SA) was developed as an alternative to the INTERMED 
Complexity Assessment Grid interview (IM-CAG) to assess biopsychosocial complexity and health care 
needs in order to optimize care. The aim of this study was to discuss possible applications of IMSA to 
routine clinical work in a CL psychiatry setting, after presenting IM-SA’s feasibility, reliability, validity and 
predictive value for health care utilization (HCU) and quality of life (QoL) as emerged by the IMSA Study.  
 
Methods 
The IMSA Study was an international multicentric prospective observational cohort study, involving 850 
participants who completed both the IM-SA and IM-CAG. Feasibility by percentages of missing values, 
reliability by Cronbach's alpha, interrater agreement by intraclass correlation coefficients (ICCs) and 
convergent validity of IM-SA scores with mental health (SF-36 mental health subscale and HADS) and 
medical health (CIRS) and discriminant validity of IM-SA scores with QoL (EQ-5D) by Spearmans rank 
correlations were determined. Predictive validity of IM-SA scores with HCU and QoL was examined by 
(generalized) linear mixed models. At Modena University Hospital, IMSA was included in several clinical 
research protocols to support screening procedures.    
Results 
Feasibility, face validity and reliability (Cronbach’s alpha 0.80) were satisfactory. ICC between IM-SA and 
IM-CAG total scores was .78 (95% CI .75–.81). Correlations of the IM-SA with the SF-36, HADS, CIRS and EQ-
5D were -.65, .002, .28 and -.59 respectively. The IM-SA predicted HCU and QoL after 3- and 6-month 
follow-up. Seven subjects suffering from comorbid HIV and depression and 30 subjects undergoing 
colonoscopy for screening were also tested with IM-SA. Mean baseline score was 17.14 (SD = 8.71) for the 
depressed HIV subjects, with 2 subjects overcoming the cutoff of 21, suggesting clinical complexity. Mean 
score was 7.72 (SD = 4.19) for subjects undergoing colonoscopy, none of whom reached a score suggesting 
clinical complexity.    
 
Conclusion 
The IM-SA may efficiently support healthcare professionals in the assessment of patient’s biopsychosocial 
complexity aimed at providing integrated, personalized multidisciplinary care. Inclusion of IM-SA as a 
routine screening tool may be advised in different clinical in- and out-patient contexts.  
 
